IQVIA Holdings Inc.
IQV
Ранг среди акций
#534
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical... IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Цена акции
$273.50
Рыночная капитализация
$45.02B
Изменение (1 день)
2.24%
Изменение (1 год)
25.07%
Страна
US
Торговля IQVIA Holdings Inc. (IQV)
Категория
Healthcare
Выручка компании IQVIA Holdings Inc. (IQV)
Выручка на Jun 2026 TTM: $16.98B
Согласно последним финансовым отчетам IQVIA Holdings Inc., текущая выручка компании (TTM) составляет $16.98B. В 2024 году компания получила выручку $15.41B больше, чем выручке в 2023 году, которая составила $14.98B. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки IQVIA Holdings Inc. с 2010 по 2026
Выручка на конец каждого года
| Год | Выручка | Изменить |
|---|---|---|
| 2026 (TTM) | $16.98B | 4.13% |
| 2025 | $16.31B | 5.87% |
| 2024 | $15.41B | 2.81% |
| 2023 | $14.98B | 3.98% |
| 2022 | $14.41B | 3.86% |
| 2021 | $13.87B | 22.14% |
| 2020 | $11.36B | 2.44% |
| 2019 | $11.09B | 6.49% |
| 2018 | $10.41B | 7.32% |
| 2017 | $9.70B | 42.36% |
| 2016 | $6.82B | 18.79% |
| 2015 | $5.74B | 5.07% |
| 2014 | $5.46B | 7.07% |
| 2013 | $5.10B | 4.81% |
| 2012 | $4.87B | 12.43% |
| 2011 | $4.33B | 10.29% |
| 2010 | $3.92B | 0.00% |
Выручка аналогичных компаний или конкурентов
| Компания | Выручка | Разница в выручке | Страна |
|---|---|---|---|
| $46.34B | 172.84% |
US
|
|
| $25.11B | 47.84% |
US
|
|
| $2.71B | -84.06% |
US
|
|
| - | - |
CN
|
|
| $7.37B | -56.59% |
US
|
